Vor Biopharma, Inc., an early stage cell therapy company, develops hematopoietic stem cell (eHSC) therapies designed for cancer patients. The company is headquartered in Cambridge, Massachusetts.
Click "Analyze" to generate stock analysis
VOR Price Trend and Signals
VOR Option Volumes & Open Interests (aggregated)
VOR Put Call Ratios and IV (aggregated)
2025-08-13Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-08-13Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-08-13Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.